Elizabeth Yeu's most recent trade in Staar Surgical Co. was a trade of 9,708 Common Stock Options done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | Elizabeth Yeu-Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 9,708 | 9,708 | - | - | Common Stock Options | |
| Staar Surgical Co. | Elizabeth Yeu-Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 5,341 | 5,341 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2025 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2025 | 3,350 | 8,700 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.08 per share. | 13 Jun 2025 | 1,006 | 7,694 | - | 41.1 | 41,326 | Common Stock |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 15,314 | 15,314 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 10,045 | 10,045 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 41,074 | 41,074 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 27,278 | 27,278 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 5,350 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Elizabeth Yeu-Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,010 | 4,010 | - | - | Common Stock Options | |
| Staar Surgical Co. | Elizabeth Yeu-Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,244 | 5,099 (0%) | 0% | 0 | Common Stock | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Purchase of securities on an exchange or from another person at price $ 16.80 per share. | 15 Aug 2023 | 9,506 | 15,866 | - | 16.8 | 159,701 | Common Stock |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 2,000 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Director | Purchase of securities on an exchange or from another person at price $ 16.03 per share. | 14 Sep 2022 | 12,040 | 12,040 | - | 16.0 | 193,001 | Common Stock |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Director | Purchase of securities on an exchange or from another person at price $ 16.29 per share. | 14 Sep 2022 | 6,360 | 6,360 | - | 16.3 | 103,604 | Common Stock |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,000 | 7,000 | - | - | Employee Stock Option (right to buy) | |
| Staar Surgical Co. | Elizabeth Yeu-Lin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 5,765 | 5,765 | - | - | Common Stock Options | |
| Tarsus Pharmaceuticals Inc | Elizabeth Yeu-Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 2,000 | 2,000 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Elizabeth Yeu-Lin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 355 | 355 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Elizabeth Yeu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 1,703 | 1,703 | - | - | Common Stock Options |